Hakan Harputluoğlu
Impact in
Papers in
- Oncology 26
- Cancer Treatment and Pharmacology 7
- HER2/EGFR in Cancer Research 5
- Lung Cancer Research Studies 5
- Inflammatory Biomarkers in Disease Prognosis 4
- Cancer Diagnosis and Treatment 3
-
- Brain Metastases and Treatment 4
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Sercan Aksoy (20 shared papers)Ömer Dızdar (12 shared papers)Kadri Altundağ (14 shared papers)Saadettin Kılıçkap (11 shared papers)Didem Şener Dede (5 shared papers)İbrahim Barışta (5 shared papers)Mutlu Hayran (3 shared papers)Mustafa Erman (6 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Annals of Oncology (3 papers)Medical Oncology (3 papers)Supportive Care in Cancer (2 papers)The FASEB Journal (1 paper)
- Partner nations
- TürkiyeUnited StatesSwitzerland
In The Last Decade
Hakan Harputluoğlu
46 papers receiving 723 citations
Peers
Comparison fields: 5 of 69
- Oncology 263
- Genetics 98
- Pathology and Forensic Medicine 102
- Hematology 56
- Hepatology 36
Countries citing papers authored by Hakan Harputluoğlu
This map shows the geographic impact of Hakan Harputluoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakan Harputluoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakan Harputluoğlu more than expected).
Fields of papers citing papers by Hakan Harputluoğlu
This network shows the impact of papers produced by Hakan Harputluoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakan Harputluoğlu. The network helps show where Hakan Harputluoğlu may publish in the future.
Co-authors
The 25 scholars most cited alongside Hakan Harputluoğlu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 190 | |
| 2 | 2009 | 80 | |
| 3 | 2009 | 60 | |
| 4 | 2007 | 46 | |
| 5 | 2011 | 43 | |
| 6 | 2013 | 28 | |
| 7 | 2008 | 26 | |
| 8 | 2008 | 25 | |
| 9 | 2010 | 23 | |
| 10 | 2005 | 21 | |
| 11 | 2008 | 18 | |
| 12 | Malignancies after rituximab treatment: just coincidence or more? | 2011 | 18 |
| 13 | 2007 | 17 | |
| 14 | 2012 | 16 | |
| 15 | 2007 | 12 | |
| 16 | 2012 | 9 | |
| 17 | 2015 | 9 | |
| 18 | 2013 | 9 | |
| 19 | 2023 | 8 | |
| 20 | 2013 | 7 |
About Hakan Harputluoğlu
Hakan Harputluoğlu is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 49 papers that have together received 734 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), HER2/EGFR in Cancer Research (5 papers), Lung Cancer Research Studies (5 papers), Brain Metastases and Treatment (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (263 citations), Genetics (98 citations), Pathology and Forensic Medicine (102 citations), Hematology (56 citations) and Hepatology (36 citations). Hakan Harputluoğlu has collaborated with scholars based in Türkiye, United States and Switzerland. Frequent co-authors include Sercan Aksoy, Ömer Dızdar, Kadri Altundağ, Saadettin Kılıçkap, Didem Şener Dede, İbrahim Barışta, Mutlu Hayran, Mustafa Erman, Yavuz Özışık and Fevziye Ünsal Malas. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Medical Oncology, Supportive Care in Cancer and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.